Industry: Health care Region: Italy Transaction price: US$ 1 million Transaction method: equity investment
Project introduction:
An Italian biotechnology company produces and sells in vitro diagnostic kits for immunodiagnosis and molecular diagnosis. Since 2021, the company has also commercialized life science products. Its product line can meet the needs of infectious diseases, cardiac markers, bone metabolism, hepatitis, tumor and endocrine and other clinical fields.
Product service introduction:
1. Immunodiagnosis
As a global leader in the laboratory diagnosis market, the company focuses on the field of immunodiagnosis, which is based on the detection of antibodies and antigens to measure the markers of physiological functions or prove the existence of diseases in liquid samples, and is applied to infectious diseases, gastrointestinal diseases, hepatitis, tumor markers and other fields.
2. Molecular diagnosis
The solution can identify the unique DNA/RNA sequence of clinically relevant pathogens, and provide rapid and cost-effective solutions based on various types of biological samples, while ensuring accuracy and meeting the needs of clinicians in laboratories around the world.
3. Authorization technology
Professional technical team provides fast and reliable answers to complex biological questions. Services include biomedical research, genomics and protein genomics, clinical diagnosis and drug discovery.
Cooperation mode:
Seek partners who need medical diagnosis technical services.